Q3 25 EPS
$10.38
MISS 3.44%
Est. $10.75
Q3 25 Revenue
$1.42B
MISS 0.78%
Est. $1.43B
vs S&P Since Q3 25
-30.1%
TRAILING MARKET
CALM +5.6% vs S&P +35.8%
Market Reaction
Did CALM Beat Earnings? Q3 2025 Results
Cal-Maine Foods delivered a blowout fiscal third quarter, posting earnings of $10.38 per share on revenue of $1.42 billion as a devastating avian flu crisis reshaped the U.S. Egg market in the company's favor. The dominant force behind the results wa… Read more Cal-Maine Foods delivered a blowout fiscal third quarter, posting earnings of $10.38 per share on revenue of $1.42 billion as a devastating avian flu crisis reshaped the U.S. Egg market in the company's favor. The dominant force behind the results was a historic collapse in industry supply, with the U.S. Table-egg layer flock falling to its lowest level since September 2015 after more than 73 million commercial hens and pullets were depopulated since the start of 2024, driving Cal-Maine's average net selling price per dozen up 80.7% year-over-year to $4.06. Net income more than tripled to $508.53 million, even as record dozens sold of 331.4 million rose 10.2%, reflecting the company's aggressive biosecurity investments that kept its flocks largely intact. Looking ahead, Cal-Maine is actively expanding capacity and announced a $258 million acquisition of breakfast foods maker Echo Lake Foods, expected to be at least mid-single-digit accretive to earnings in fiscal 2026, though a DOJ antitrust inquiry into egg pricing adds a layer of uncertainty to the outlook.
Key Takeaways
- • Net average selling price per dozen surged to $4.060 from $2.247 in prior-year quarter due to HPAI-driven supply shortages
- • Record total dozens sold of 331.4 million, a 10.2% increase year-over-year
- • 14% increase in average number of layer hens during the quarter compared to prior year
- • Feed costs per dozen declined 9.6% year-over-year due to more favorable commodity pricing
- • Strong consumer demand during peak seasonal period, amplified by severe weather events and GLP-1 medication-related egg consumption recommendations
- • Farm production costs per dozen were 5.7% lower than the prior-year period
CALM YoY Financials
Q3 2025 vs Q3 2024, source: SEC Filings
CALM Revenue by Segment
With YoY comparisons, source: SEC Filings
“Dynamic market conditions and HPAI-related supply shortages persisted this quarter. However, the entire Cal-Maine Foods team did an outstanding job in maximizing production through a period of high demand, while operating safely and maintaining diligence on biosecurity measures. We were fortunate to have the ability to utilize our existing operational scale and to benefit from recent acquisitions, which helped increase our production capacity in this challenging supply environment. Above all, we stayed focused on meeting the needs of our valued customers, while honoring our long-standing pricing frameworks.”
— Sherman Miller, Q3 2025 Earnings Press Release
CALM Earnings Trends
CALM vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
CALM EPS Trend
Earnings per share: estimate vs actual
CALM Revenue Trend
Quarterly revenue: estimate vs actual
CALM Quarterly Results
5 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q3 26 BEAT | $0.78 | $1.06 | +35.90% | $667.0M | +3.81% |
| Q2 26 BEAT | $2.01 | $2.13 | +6.23% | $769.5M | -6.88% |
| Q1 26 MISS | $5.35 | $4.12 | -22.99% | $922.6M | -3.13% |
| Q4 25 BEAT FY | $5.29 | $7.04 | +33.21% | $1.10B | +25.84% |
| FY Full Year | $23.21 | $24.95 | +7.52% | $4.26B | +5.65% |
| Q3 25 MISS | $10.75 | $10.38 | -3.44% | $1.42B | -0.78% |